JEDI launches billion molecules agains COVID19 challenge

The Joint European Disruptive Initiative (JEDI) has launched a new initiative to bring together the world's scientists for a united attack against the novel coronavirus pandemic.

The Billion Molecules against Covid19 Grand Challenge, which is open to scientific and technology teams around the world, has one objective - to screen billions of molecules with blocking interactions on SARS-CoV-2, and ultra-fast track the route to the development of a vaccine.

For Stage 1 of the project, which runs until June 6, participant teams will, 'at a scale never seen before', screen enormous molecular libraries against protein targets of the virus, using supercomputing and artificial intelligence (AI).

These results will then be cross-correlated to determine a 'high potential list of unprecedented quality', allowing a fast track to clinical testing, the group noted.

“It is great to see that scientists are bundling forces in an unprecedented manner, sharing data and experiments at a global scale,” said Thomas Hermans, Program Manager of the #JEDICovid19Challenge.

“This Challenge builds on the collective knowledge of the best teams in computational drug discovery, and adds rapid experimental validation, to find new or existing compounds to block SARS-CoV-2, in record time.”

CPhI China 2020 To Be Postponed to Dec. 16-18th,

Register as Visitor to the 20th Edition of CPhI China!

-----------------------------------------------------------------------
Editor's Note:

To become a freelance writer of PharmaSources.com,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@imsinoexpo.com.